DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
52 hedge funds and large institutions have $14.6M invested in DMK Pharmaceuticals Corporation Common Stock in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $17.8M → $14.6M (-$3.17M)
Holders
52
Holding in Top 10
–
Calls
$2.53M
Puts
$713K
Top Buyers
| 1 | +$525K | |
| 2 | +$476K | |
| 3 | +$199K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$190K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$66.4K |
Top Sellers
| 1 | -$1.78M | |
| 2 | -$685K | |
| 3 | -$266K | |
| 4 |
Squarepoint
New York
|
-$99.2K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$67.9K |